Jul 17, 2024 8:00am EDT Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
Jun 11, 2024 8:20am EDT Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer